SquareSocialBook Banner-2560x1440-Pre-Pub
Entrepreneur Greg Lindberg Publishes Audio Version of Latest Groundbreaking Book on Anti-Aging, Longevity and Leadership
08. Mai 2024 13:48 ET | Lifelong Labs
Greg Lindberg Releases Audio Version of his Book Lifelong
Crossject - Rapport
Crossject - Rapport financier annuel 2022
28. April 2023 12:16 ET | CROSSJECT
CROSSJECT RAPPORT FINANCIER 2022 Pièce jointe CROSSJECT RAPPORT FINANCIER 2022 ...
CROSSJECT - 2022 Ann
CROSSJECT - 2022 Annual Results
20. März 2023 15:35 ET | CROSSJECT
Press release 2022 annual resultsA year of major developmentsSubstantial increase in operating income Dijon, 20 March 2023, 8.00 p.m. CROSSJECT (ISIN: FR0011716265; Ticker: ALCJ), a specialty...
CROSSJECT - Résultat
CROSSJECT - Résultats annuels 2022
20. März 2023 15:35 ET | CROSSJECT
Communiqué de Presse Résultats annuels 2022Une année de développements majeursForte hausse des produits d’exploitation Dijon, le 20 mars 2023 à 20h CROSSJECT (ISIN : FR0011716265 ; Mnémo :...
CROSSJECT - CALENDRI
CROSSJECT - CALENDRIER FINANCIER 2023
01. Februar 2023 12:00 ET | CROSSJECT
Communiqué de Presse CALENDRIER FINANCIER 2023 Dijon, le 1er février 2023 à 18h CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui développe et commercialisera prochainement...
VIPC’s Virginia Venture Partners Invests in Magazine Jukebox, Inc. to Provide Digital Alternative to Traditional Magazine Displays
VIPC’s Virginia Venture Partners Invests in Magazine Jukebox, Inc. to Provide Digital Alternative to Traditional Magazine Displays Richmond, VA, May 17, 2022 (GLOBE NEWSWIRE) -- Virginia Venture Partners, the equity investment program of Virginia Innovation Partnership Corporation (VIPC), today announced an investment in...
SD logo
Special Education Publisher Awarded $3.25 Million in Damages
26. April 2022 10:14 ET | Super Duper Publications
GREENVILLE, S.C., April 26, 2022 (GLOBE NEWSWIRE) -- A federal court in New York City has ordered PresenceLearning, a nationwide online teletherapy company, to pay educational publisher Super Duper...
Logo-uniQure-MS-Word_Orange.jpg
uniQure Announces Publications of Preclinical Data for AMT-130 in Huntington’s Disease Showing Safety of Administration in NHPs and Widespread Long-Term HTT-Lowering in the Brain
08. April 2021 07:05 ET | uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, April 08, 2021 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical...
Logo-uniQure-MS-Word_Orange.jpg
uniQure Announces Publication of Preclinical Data for AMT-130 in Huntington’s Disease Supporting Non-Selective HTT-Lowering Approach
19. Dezember 2019 07:00 ET | uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Dec. 19, 2019 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with...